tirzepatide and joint inflammation In a patient with diabetes on (Mounjaro) 7.5 mg biweekly who develops pain, what alternative glucose‑lowering agent is recommended? Does Tirzepatide Help With Inflammation?

Both programs include the same clinical infrastructure: comprehensive labs, InBody body composition tracking, monthly provider check-ins, and a long-term maintenance plan

Latest 2024 Research on GLP-1 and GIP Medications Advancements in GLP-1 Research Recent studies in 2024 have continued to affirm the efficacy of GLP-1 medications in promoting weight loss and improving metabolic health

Short Chain Fatty Acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases

Clinicians should assess and remain vigilant for potential use (or misuse) of these agents, ensuring that patients are monitored closely for any signs of developing or worsening EDs